In the last few years, endovascular therapy has become a valid alternative to the traditional surgical treatment of the aneurysmal disease. However, in spite of the existing guidelines, there is still a great degree of variability from one medical center to another vis a vis both the supra-renal and infra-renal aneurysmal disease treatments. Great expectations have grown particularly in the treatment of thoracic and abdominal aneurysms with mixed results. We have certainly seen technological progress that has made it possible to extend the treatment application but many questions still remain. More than ever, greater dialogue between clinicians, engineers and manufacturers is desirable in order to speed up the introduction of new technologies and reduce false hopes in treatments that often do not have a proven long term effectiveness.
Endovascular treatment of aortic aneurysms: durable solution / Gennai, S; Leone, N; Migliari, M; Munari, E; Silingardi, R. - (2018), pp. 50-60.
Endovascular treatment of aortic aneurysms: durable solution
Leone N;Migliari M;
2018
Abstract
In the last few years, endovascular therapy has become a valid alternative to the traditional surgical treatment of the aneurysmal disease. However, in spite of the existing guidelines, there is still a great degree of variability from one medical center to another vis a vis both the supra-renal and infra-renal aneurysmal disease treatments. Great expectations have grown particularly in the treatment of thoracic and abdominal aneurysms with mixed results. We have certainly seen technological progress that has made it possible to extend the treatment application but many questions still remain. More than ever, greater dialogue between clinicians, engineers and manufacturers is desirable in order to speed up the introduction of new technologies and reduce false hopes in treatments that often do not have a proven long term effectiveness.Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris